Organoids Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Organ Type, Application, Source, Type, and Geography

Description

List of Tables

The organoids market is expected to grow from US$ 2.507 billion in 2022 to US$ 12.206 billion by 2030; it is estimated to register a CAGR of 21.9% from 2022 to 2030. The higher demand for tumor modeling and biobanking, growing adoption of personalized drugs, and rising focus on developing alternatives for animal testing models drive the organoids market growth. The organoids market trends include combining organoids with organ-on-a-chip.

The organoids are tiny, self-organized, three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ or to express selected aspects of it, like producing only certain types of cells. Organoids grow from stem cells-cells that can divide indefinitely and produce different types of cells as part of their progeny. Organoids can range in size from less than the width of a hair to five millimeters.

Many market players and research institutes operating in the organoids market are developing advanced technologies to expand their product portfolios and increase their market shares. A few of the recent developments related to organoids are mentioned below:

In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.

Thus, the development is likely to introduce new trends in the organoids market during the forecast period.

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study 'CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,' published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research.

Thus, such innovations are expected to offer more significant growth opportunities for organoids market growth.

Application-Based Insights

Based on application, the organoids market is divided into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. In 2022, the developmental biology held the largest share of the market and drug discovery & personalized medicine is anticipated to register the highest CAGR during the forecast period.

Source-Based Insights

Based on source, the organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.

The World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine are a few of the major primary and secondary sources referred to while preparing the report on the organoids market.

Type-Based Insights

Based on type, the organoids market is bifurcated into instruments, consumables, and services. The consumables segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the organoids market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Product Code: TIPRE00017616

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Organoids Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 South & Central America PEST Analysis
- 4.2.5 Middle East & Africa PEST Analysis

5. Organoids Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
- 5.1.2 Growing Adoption of Personalized Drugs
- 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Key Market Restraints:
- 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
- 5.2.2 Dearth of Skilled Professionals
5.3 Key Market Opportunities:
- 5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends:
- 5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis:

6. Organoids Market - Global Market Analysis

6.1 Organoids Market Revenue (US$ Mn), 2022 - 2030

7. Global Organoids Market - Revenue and Forecast to 2030 - by Organ Type

7.1 Overview
7.2 Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Intestine
- 7.4.1 Overview
- 7.4.2 Intestine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Liver
- 7.5.1 Overview
- 7.5.2 Liver: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Pancreas
- 7.6.1 Overview
- 7.6.2 Pancreas: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Lung
- 7.7.1 Overview
- 7.7.2 Lung: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Brain
- 7.8.1 Overview
- 7.8.2 Brain: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.9 Kidney
- 7.9.1 Overview
- 7.9.2 Kidney: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.10 Others
- 7.10.1 Overview
- 7.10.2 Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Organoids Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Organoids Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Developmental Biology
- 8.3.1 Overview
- 8.3.2 Developmental Biology: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Disease Pathology of Infectious Disease
- 8.4.1 Overview
- 8.4.2 Disease Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Regenerative Medicine
- 8.5.1 Overview
- 8.5.2 Regenerative Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
- 8.6.1 Overview
- 8.6.2 Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
- 8.7.1 Overview
- 8.7.2 Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Organoids Market - Revenue and Forecast to 2030 - by Source

9.1 Overview
9.2 Organoids Market Revenue Share, by Source 2022 & 2030 (%)
9.3 Pluripotent Stem Cells
- 9.3.1 Overview
- 9.3.2 Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Organ-specific Adult Stem Cells
- 9.4.1 Overview
- 9.4.2 Organ-specific Adult Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Organoids Market - Revenue and Forecast to 2030 - by Type

10.1 Overview
10.2 Organoids Market Revenue Share, by Type 2022 & 2030 (%)
10.3 Instruments
- 10.3.1 Overview
- 10.3.2 Instruments: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Consumables
- 10.4.1 Overview
- 10.4.2 Consumables: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Services
- 10.5.1 Overview
- 10.5.2 Services: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. Organoids Market - Geographical Analysis

11.1 North America Organoids Market, Revenue And Forecast To 2030
- 11.1.1 Overview
- 11.1.2 North America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.3 North America Organoids Market, by Organ Type
- 11.1.4 North America Organoids Market, by Application
- 11.1.5 North America Organoids Market, by Source
- 11.1.6 North America Organoids Market, by Type
- 11.1.7 North America Organoids Market, by Country
  - 11.1.7.1 US
    - 11.1.7.1.1 Overview
    - 11.1.7.1.2 US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.7.1.3 US Organoids Market, by Organ Type
    - 11.1.7.1.4 US Organoids Market, by Application
    - 11.1.7.1.5 US Organoids Market, by Source
    - 11.1.7.1.6 US Organoids Market, by Type
  - 11.1.7.2 Canada
    - 11.1.7.2.1 Overview
    - 11.1.7.2.2 Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.7.2.3 Canada Organoids Market, by Organ Type
    - 11.1.7.2.4 Canada Organoids Market, by Application
    - 11.1.7.2.5 Canada Organoids Market, by Source
    - 11.1.7.2.6 Canada Organoids Market, by Type
  - 11.1.7.3 Mexico
    - 11.1.7.3.1 Overview
    - 11.1.7.3.2 Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.7.3.3 Mexico Organoids Market, by Organ Type
    - 11.1.7.3.4 Mexico Organoids Market, by Application
    - 11.1.7.3.5 Mexico Organoids Market, by Source
    - 11.1.7.3.6 Mexico Organoids Market, by Type
11.2 Europe Organoids Market, Revenue And Forecast to 2030
- 11.2.1 Overview
- 11.2.2 Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.3 Europe Organoids Market, by Organ Type
- 11.2.4 Europe Organoids Market, by Application
- 11.2.5 Europe Organoids Market, by Source
- 11.2.6 Europe Organoids Market, by Type
- 11.2.7 Europe Organoids Market by Country
  - 11.2.7.1 Germany
    - 11.2.7.1.1 Overview
    - 11.2.7.1.2 Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.1.3 Germany Organoids Market, by Organ Type
    - 11.2.7.1.4 Germany Organoids Market, by Application
    - 11.2.7.1.5 Germany Organoids Market, by Source
    - 11.2.7.1.6 Germany Organoids Market, by Type
  - 11.2.7.2 UK
    - 11.2.7.2.1 Overview
    - 11.2.7.2.2 UK Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.2.3 UK Organoids Market, by Organ Type
    - 11.2.7.2.4 UK Organoids Market, by Application
    - 11.2.7.2.5 UK Organoids Market, by Source
    - 11.2.7.2.6 UK Organoids Market, by Type
  - 11.2.7.3 France
    - 11.2.7.3.1 Overview
    - 11.2.7.3.2 France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.3.3 France Organoids Market, by Organ Type
    - 11.2.7.3.4 France Organoids Market, by Application
    - 11.2.7.3.5 France Organoids Market, by Source
    - 11.2.7.3.6 France Organoids Market, by Type
  - 11.2.7.4 Italy
    - 11.2.7.4.1 Overview
    - 11.2.7.4.2 Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.4.3 Italy Organoids Market, by Organ Type
    - 11.2.7.4.4 Italy Organoids Market, by Application
    - 11.2.7.4.5 Italy Organoids Market, by Source
    - 11.2.7.4.6 Italy Organoids Market, by Type
  - 11.2.7.5 Spain
    - 11.2.7.5.1 Overview
    - 11.2.7.5.2 Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.5.3 Spain Organoids Market, by Organ Type
    - 11.2.7.5.4 Spain Organoids Market, by Application
    - 11.2.7.5.5 Spain Organoids Market, by Source
    - 11.2.7.5.6 Spain Organoids Market, by Type
  - 11.2.7.6 Rest of Europe
    - 11.2.7.6.1 Overview
    - 11.2.7.6.2 Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.6.3 Rest of Europe Organoids Market, by Organ Type
    - 11.2.7.6.4 Rest of Europe Organoids Market, by Application
    - 11.2.7.6.5 Rest of Europe Organoids Market, by Source
    - 11.2.7.6.6 Rest of Europe Organoids Market, by Type
11.3 Asia Pacific Organoids Market, Revenue And Forecast to 2030
- 11.3.1 Overview
- 11.3.2 Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.3 Asia Pacific Organoids Market, by Organ Type
- 11.3.4 Asia Pacific Organoids Market, by Application
- 11.3.5 Asia Pacific Organoids Market, by Source
- 11.3.6 Asia Pacific Organoids Market, by Type
- 11.3.7 Asia Pacific Organoids Market by Country
  - 11.3.7.1 China
    - 11.3.7.1.1 Overview
    - 11.3.7.1.2 China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.1.3 China Organoids Market, by Organ Type
    - 11.3.7.1.4 China Organoids Market, by Application
    - 11.3.7.1.5 China Organoids Market, by Source
    - 11.3.7.1.6 China Organoids Market, by Type
  - 11.3.7.2 Japan
    - 11.3.7.2.1 Overview
    - 11.3.7.2.2 Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.2.3 Japan Organoids Market, by Organ Type
    - 11.3.7.2.4 Japan Organoids Market, by Application
    - 11.3.7.2.5 Japan Organoids Market, by Source
    - 11.3.7.2.6 Japan Organoids Market, by Type
  - 11.3.7.3 India
    - 11.3.7.3.1 Overview
    - 11.3.7.3.2 India Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.3.3 India Organoids Market, by Organ Type
    - 11.3.7.3.4 India Organoids Market, by Application
    - 11.3.7.3.5 India Organoids Market, by Source
    - 11.3.7.3.6 India Organoids Market, by Type
  - 11.3.7.4 Australia
    - 11.3.7.4.1 Overview
    - 11.3.7.4.2 Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.4.3 Australia Organoids Market, by Organ Type
    - 11.3.7.4.4 Australia Organoids Market, by Application
    - 11.3.7.4.5 Australia Organoids Market, by Source
    - 11.3.7.4.6 Australia Organoids Market, by Type
  - 11.3.7.5 South Korea
    - 11.3.7.5.1 Overview
    - 11.3.7.5.2 South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.5.3 South Korea Organoids Market, by Organ Type
    - 11.3.7.5.4 South Korea Organoids Market, by Application
    - 11.3.7.5.5 South Korea Organoids Market, by Source
    - 11.3.7.5.6 South Korea Organoids Market, by Type
  - 11.3.7.6 Rest of Asia Pacific
    - 11.3.7.6.1 Overview
    - 11.3.7.6.2 Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.6.3 Rest of Asia Pacific Organoids Market, by Organ Type
    - 11.3.7.6.4 Rest of Asia Pacific Organoids Market, by Application
    - 11.3.7.6.5 Rest of Asia Pacific Organoids Market, by Source
    - 11.3.7.6.6 Rest of Asia Pacific Organoids Market, by Type
11.4 Middle East & Africa Organoids Market, Revenue and Forecast to 2030
- 11.4.1 Overview
- 11.4.2 Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.3 Middle East & Africa Organoids Market, by Organ Type
- 11.4.4 Middle East & Africa Organoids Market, by Application
- 11.4.5 Middle East & Africa Organoids Market, by Source
- 11.4.6 Middle East & Africa Organoids Market, by Type
- 11.4.7 Middle East & Africa Organoids Market by Country
  - 11.4.7.1 Saudi Arabia
    - 11.4.7.1.1 Overview
    - 11.4.7.1.2 Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.7.1.3 Saudi Arabia Organoids Market, by Organ Type
    - 11.4.7.1.4 Saudi Arabia Organoids Market, by Application
    - 11.4.7.1.5 Saudi Arabia Organoids Market, by Source
    - 11.4.7.1.6 Saudi Arabia Organoids Market, by Type
  - 11.4.7.2 UAE
    - 11.4.7.2.1 Overview
    - 11.4.7.2.2 UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.7.2.3 UAE Organoids Market, by Organ Type
    - 11.4.7.2.4 UAE Organoids Market, by Application
    - 11.4.7.2.5 UAE Organoids Market, by Source
    - 11.4.7.2.6 UAE Organoids Market, by Type
  - 11.4.7.3 South Africa
    - 11.4.7.3.1 Overview
    - 11.4.7.3.2 South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.7.3.3 South Africa Organoids Market, by Organ Type
    - 11.4.7.3.4 South Africa Organoids Market, by Application
    - 11.4.7.3.5 South Africa Organoids Market, by Source
    - 11.4.7.3.6 South Africa Organoids Market, by Type
  - 11.4.7.4 Rest of Middle East & Africa
    - 11.4.7.4.1 Overview
    - 11.4.7.4.2 Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.7.4.3 Rest of Middle East & Africa Organoids Market, by Organ Type
    - 11.4.7.4.4 Rest of Middle East & Africa Organoids Market, by Application
    - 11.4.7.4.5 Rest of Middle East & Africa Organoids Market, by Source
    - 11.4.7.4.6 Rest of Middle East & Africa Organoids Market, by Type
11.5 South & Central America Organoids Market, Revenue and Forecast to 2030
- 11.5.1 Overview
- 11.5.2 South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.3 South & Central America Organoids Market, by Organ Type
- 11.5.4 South & Central America Organoids Market, by Application
- 11.5.5 South & Central America Organoids Market, by Source
- 11.5.6 South & Central America Organoids Market, by Type
- 11.5.7 South & Central America Organoids Market by Country
  - 11.5.7.1 Brazil
    - 11.5.7.1.1 Overview
    - 11.5.7.1.2 Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.7.1.3 Brazil Organoids Market, by Organ Type
    - 11.5.7.1.4 Brazil Organoids Market, by Application
    - 11.5.7.1.5 Brazil Organoids Market, by Source
    - 11.5.7.1.6 Brazil Organoids Market, by Type
  - 11.5.7.2 Argentina
    - 11.5.7.2.1 Overview
    - 11.5.7.2.2 Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.7.2.3 Argentina Organoids Market, by Organ Type
    - 11.5.7.2.4 Argentina Organoids Market, by Application
    - 11.5.7.2.5 Argentina Organoids Market, by Source
    - 11.5.7.2.6 Argentina Organoids Market, by Type
  - 11.5.7.3 Rest of South & Central America
    - 11.5.7.3.1 Overview
    - 11.5.7.3.2 Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.7.3.3 Rest of South & Central America Organoids Market, by Organ Type
    - 11.5.7.3.4 Rest of South & Central America Organoids Market, by Application
    - 11.5.7.3.5 Rest of South & Central America Organoids Market, by Source
    - 11.5.7.3.6 Rest of South & Central America Organoids Market, by Type

12. Pre & Post Covid-19 Impact

12.1 Pre & Post Covid-19 Impact

13. Organoids Market Industry Landscape

13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
- 13.3.1 Overview
13.4 Inorganic Developments
- 13.4.1 Overview

14. Organoids Market, Key Company Profiles

14.1 STEMCELL Technologies Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Cellesce Ltd
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Hubrecht Organoid Technology
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Definigen
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Organoid Therapeutics
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 3Dnamics Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Thermo Fisher Scientific Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Corning Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Merck KGaA
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 InSphero
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About Us
15.2 Glossary of Terms